Nordmann P, Carrer A
Service de Bactériologie-Virologie-Hygiène, Hôpital de Bicêtre, 78, Rue du Général Leclerc, 94275 Le Kremlin-Bicêtre, France.
Arch Pediatr. 2010 Sep;17 Suppl 4:S154-62. doi: 10.1016/S0929-693X(10)70918-0.
Carbapenem-hydrolyzing beta-lactamases are the most powerful mechanism of resistance to carbapenems. Carbapenemases have been reported extensively worldwide now in Enterobacteriaceae. Carbapenemases of the KPC type have been reported first from the USA in Klebsiella pneumoniae, then worldwide with a marked endemicity in Israel and Greece. Metallo-enzymes (VIM, IMP…) have been also reported internationnaly with high prevalence in Southern Europe and Asia. OXA-48 which is one of the latest carbapenemases reported differs structurally from the other carbapenemases and have been identified mostly from Mediterranean countries. These carbapenemase genes are mostly plasmid located in K. pneumoniae from nosocomial origin. They have been also identified as a source of community-acquired infections. Carbapenemase producers are also multidrug resistant explaining the difficulty to treat infections. Detection of infected patients and carriers remain difficult which may explain an underlying spread with dramatic therapeutic consequences.
碳青霉烯水解β-内酰胺酶是对碳青霉烯类耐药的最强大机制。目前,碳青霉烯酶在全球范围内的肠杆菌科细菌中被广泛报道。KPC型碳青霉烯酶首先在美国的肺炎克雷伯菌中被报道,随后在全球范围内出现,在以色列和希腊有明显的地方性流行。金属酶(VIM、IMP等)也在国际上被报道,在南欧和亚洲流行率较高。OXA-48是最新报道的碳青霉烯酶之一,其结构与其他碳青霉烯酶不同,主要在地中海国家被发现。这些碳青霉烯酶基因大多位于医院来源的肺炎克雷伯菌的质粒上。它们也被确定为社区获得性感染的一个来源。产碳青霉烯酶的细菌也具有多重耐药性,这解释了治疗感染的困难。对感染患者和携带者的检测仍然困难,这可能解释了其潜在的传播以及严重的治疗后果。